Although the cancer-promoting effect of LPS-TLR4 signaling is probably negligible at gut homeostasis, it could be markedly increased in IBD, where Gram-negative bacteria such as E. coli are abundantly present and the host gut barrier function and immune system are impaired. The gene discussed is TLR4; the disease is cancer.